CLARITRON

This brand name is authorized in Nigeria. It is also authorized in Hong Kong SAR China, Singapore.

Active ingredients

The drug CLARITRON contains one active pharmaceutical ingredient (API):

1	Clarithromycin UNII H1250JIK0A - CLARITHROMYCIN
	Clarithromycin is a semi-synthetic derivative of erythromycin A. It exerts its antibacterial action by selectively binding to the 50s ribosomal sub-unit of susceptible bacteria preventing translocation of activated amino acids. It inhibits the intracellular protein synthesis of susceptible bacteria.
	Read more about Clarithromycin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-4760	Tablet	CLARITRON TABLETS TAB 500 mg 2 X 7	CLARITRON TABLETS CLARITRON CLARITHROMYCIN USP 500MG POM TABLETS 2 X 7 ANTIBIOTIC STRIDES LIFESCIENCES LTD 7, OBASA STREET, OFF OBA AKRAN AVE., IKEJA, LAGOS OSAKA PHARMACEUTICALS LTD OLD NATIONAL HIGHWAY NO 8 SANKARDA 391 350 DIST. VADODARA, GUJARAT, INDIA GMP- SATIS; LR- SATIS; FEES- PAID; NP: NA 08/06/2018 R R R A4-4760	30/01/2020

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01FA09	Clarithromycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FA Macrolides
Discover more medicines within J01FA09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
HK	Department of Health Drug Office	60240
NG	Registered Drug Product Database	A4-4760
SG	Health Sciences Authority	13923P